A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)

NCT02969655 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaemia

Interventions

DRUG: Daprodustat small
DRUG: Daprodustat small placebo
DRUG: Daprodustat large
DRUG: Daprodustat large placebo
DRUG: Darbepoetin alfa
DRUG: Darbepoetin alfa placebo

Sponsor

GlaxoSmithKline